SWOG clinical trial number
E8897

Correlation of Histopathology, Immunohistochemistry and Quantitative Radiology with Outcome in Early Stage Nonseminomatous Germ Cell Tumor

Closed
Phase
Abbreviated Title
Testicular
Activated
10/01/2002
Closed
12/28/2004
Participants
NCORP, Members, UCOP, Medical Oncologists, Radiation Oncologists, Surgeons, Pathologists

Research committees

Genitourinary Cancer

Treatment

Surgery

Eligibility Criteria Expand/Collapse

Pts must have clinical Stage A nonseminomatous germ cell tumor of the testis. AFP and HCG must be normal or falling after orchiectomy at a rate consistent w/known half lives. Pt must have no evidence of mets on PE, chest x-ray, or abd/pelvic CT w/in 4 wks from reg. Pts must have had radical inguinal orchiectomy or simultaneous orchiectomy and RPLND w/in 12 wks prior to reg. Pt must have no hx of malignancy including prior testis primary. Pt must have pure seminoma (unless assoc w/elev AFP at dx). Pts must not be managed w/primary chemo. Pts must be >/= 15 years.

Other Clinical Trials

SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"

Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200
SWOG Clinical Trial Number
CTSU/A031901